Curebase Stock

Curebase is a provider of decentralized clinical research software solutions and services to patients and medical providers.

Sign up today and learn more about Curebase Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Curebase Stock

Curebase builds a digital clinical trial assistant that would alter how medical providers discover, activate, and administer clinical trials for their patients. It aims to run clinical trials faster and cheaper than anyone else via software that reduces recruitment times, automates manual steps, and lets drug companies distribute their trials to clinics. The company was established in 2017 and is based in San Francisco, California.


Funding History

August 2018$120K
October 2018$2.5M
May 2021$15.0M


Founder & CEO

Tom Lemberg


Matthew Rials


Jeff Richards

Vice President Of Business Development

Wayne Bowden

Chief Operating Officer

Storm Stillman


vcnewsdaily - May, 6 2022

Curebase Lands $40M Series B Round

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: